Literature DB >> 1679451

Neurobehavioral effects of antihypertensive medications.

M F Muldoon1, S B Manuck, A P Shapiro, S R Waldstein.   

Abstract

Although millions of hypertensive individuals receive chronic treatment with antihypertensive medication, the effect on the central nervous system by these drugs is poorly understood. Such treatment, while generally well tolerated, frequently produces symptoms of drowsiness, weakness, altered memory and impaired concentration. In addition to subjective evidence derived from patient reports, a large number of investigations have now been published which attempt to objectively assess the influence of antihypertensive medication on behavioral or cognitive performance. This paper summarizes and critically evaluates experimental studies of the effect of antihypertensive medication on subjects' performance of neuropsychological tasks and reviews the pharmacologic mechanisms by which these drugs may affect behavior. The literature is incomplete in its assessment of all domains of neuropsychological performance and all drug classes, and methodologic deficiencies are common. Nonetheless, the consensus of all studies and the findings of well-designed studies in particular do not identify any notable areas of performance impairment in patients receiving antihypertensive medication. Moreover, results suggest that, in certain instances, drug treatment may even enhance performance. In light of the limitations of the literature, however, an adequate understanding of the effects of antihypertensive therapy on behavioral functioning awaits completion of large, well-designed investigations including all major drug classes and thorough neurobehavioral assessments.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679451     DOI: 10.1097/00004872-199106000-00011

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  8 in total

Review 1.  The relationship between blood pressure and cognitive function.

Authors:  Vera Novak; Ihab Hajjar
Journal:  Nat Rev Cardiol       Date:  2010-10-26       Impact factor: 32.419

Review 2.  Drug-induced cognition disorders in the elderly: incidence, prevention and management.

Authors:  S L Gray; K V Lai; E B Larson
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

Review 3.  Stress management techniques: are they all equivalent, or do they have specific effects?

Authors:  P M Lehrer; R Carr; D Sargunaraj; R L Woolfolk
Journal:  Biofeedback Self Regul       Date:  1994-12

4.  Factors associated with low cognitive performance in general practice.

Authors:  M J Dealberto; B Sauron; C Derouesné; P Boyer; D Mayeux; F Piette; F Kohler; S Lubin; A Alpérovitch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 5.  Antihypertensive agents for aging patients who are at risk for cognitive dysfunction.

Authors:  Ihab Hajjar; Michelle Keown; Brandy Frost
Journal:  Curr Hypertens Rep       Date:  2005-12       Impact factor: 5.369

Review 6.  Primary hypertension and neurocognitive and executive functioning in school-age children.

Authors:  Juan C Kupferman; Marc B Lande; Heather R Adams; Steven G Pavlakis
Journal:  Pediatr Nephrol       Date:  2012-06-13       Impact factor: 3.714

Review 7.  Neurocognitive alterations in hypertensive children and adolescents.

Authors:  Marc B Lande; Juan C Kupferman; Heather R Adams
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-21       Impact factor: 3.738

8.  Characteristics of neuropsychological functions in inpatients with poorly-controlled type 2 diabetes mellitus.

Authors:  Ai Takeuchi; Eisuke Matsushima; Motoichiro Kato; Mika Konishi; Hajime Izumiyama; Yuji Murata; Yukio Hirata
Journal:  J Diabetes Investig       Date:  2012-06-06       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.